MoCA vs SLUMS: Which Memory Test Is Better for Detecting Dementia?

The Montreal Cognitive Assessment is a 30-point cognitive screening test that typically takes 10–15 minutes. It evaluates:

A score below 26 out of 30 may indicate cognitive impairment using the conventional cutoff. That number is a starting point, not a verdict: age, education, language, and clinical circumstances all influence how a score should be interpreted. For a broader look at what goes into a memory workup, see What Tests Are Ordered When Evaluating for Dementia?.

The Saint Louis University Mental Status Examination is also a 30-point cognitive screening test. It typically takes approximately 7–15 minutes and evaluates:

SLUMS uses education-adjusted screening thresholds. For individuals with at least a high school education:

For individuals with less than a high school education, the thresholds differ. These are screening classifications, not definitive diagnoses.

Both tests can detect cognitive impairment, including mild cognitive impairment. The MoCA is extensively used in neurology clinics and research. The SLUMS is also a useful clinical screening instrument and includes tasks such as story recall, calculations, and clock drawing.

There is no single universally superior test for every patient. The choice depends on the clinical setting, patient characteristics, examiner training, and the purpose of the assessment. If a screening result is unclear or concerning, an experienced dementia specialist can help decide what testing makes sense next.

Yes. A normal screening score does not completely exclude early cognitive impairment, especially in highly educated individuals or patients with subtle symptoms. Conversely, an abnormal score does not automatically mean Alzheimer's disease.

Depression, sleep disorders, medication effects, sensory impairment, language differences, and other medical conditions can all influence test performance. That is why screening scores are read alongside the whole clinical picture — and why conditions such as mild cognitive impairment and the difference between Alzheimer's and dementia deserve a proper evaluation rather than a single test score.

An abnormal screening result is a reason to look further, not a conclusion. Further evaluation may include:

Early evaluation helps identify potentially treatable contributors and clarify the diagnosis. To understand what comes next after a screening result raises a question, see What Happens After a Dementia Assessment?, how new Alzheimer's blood tests fit into the picture, and how normal aging differs from dementia. Our memory loss evaluation and Memory & Dementia hub explain the full process.